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I.

ABSTRACT

Background and Objectives
Breast cancer has the highest incidence rates among women and is the
second leading cause of death due to cancer in women. Of all breast cancers, triple
negative breast cancer (TNBC) accounts for about one-fifth of breast cancer and
tends to result in an aggressive form with larger tumors and rates of metastasis and
is more frequently found in younger women. This results in an important need in
information regarding the risk of diagnosis with triple negative breast cancer over
other forms and covariates associated with death and TNBC. This paper studies the
relationship between race, tobacco use, age, family history, marital status, insurance
status, and menopausal status at diagnosis and the risk of mortality from TNBC.
Methods
Individual breast cancer patient data collected from the Kentucky Cancer
Registry were analyzed to determine the association of potential risk factors with
TNBC. The data was collected between 2009 and 2014 and contained individuals
aged 18 or older that were diagnosed with breast cancer. Univariate and bivariate
analysis were used to determine the characteristics of the study population. Logistic
regression was used to determine the odds ratios for the covariates of interest in
TNBC patients. Survival curves were used to compare survival for TNBC patients
compared to all other breast cancer subtypes, and Cox proportional-hazard
regression was used to determine the risk of death due to TNBC.

	
  
Results
Significant increases in the odds for death due to TNBC were seen with
women who were widowed (OR 1.53; 95% CI: 1.01, 2.33), on Medicare (OR 2.90;
95% CI: 1.77, 4.74), uninsured (OR 3.84; 95% CI: 1.85, 8.00), or had a late stage at
diagnosis (OR 9.462; 95% CI: 6.616, 13.531). These results are based on married
women, privately insured women and women diagnosed at an early stage as the
reference categories. There was a statistically significant difference between the
survival curves for TNBC and all other subtypes (log-rank p<0.0001); patients with
TNBC had a lower probability of survival than those with other breast cancer
subtypes. TNBC patients that were single (HR: 1.63; 95% CI: 1.06, 2.50), on
Medicaid (HR: 1.81; 95% CI: 1.13, 2.88), on Medicare (HR: 2.73; 95% CI: 1.77,
4.20), uninsured (HR: 2.98; 95% CI: 1.57, 5.68), or diagnosed at a late stage (HR:
6.54; 95% CI: 5.03, 8.49) had a significantly higher hazard of death when compared
with patients who were married, patients that were privately insured and patients that
were diagnosed at an early stage.
Conclusions
The study results show that marital and insurance status may be related to an
increase of death due to TNBC. The results support findings from previous studies
as well as expand upon previous studies by separating based on breast cancer
subtype. Overall, continued screening can help with early diagnosis and treatment.
Because TNBC is an aggressive subtype, early diagnosis and treatment may help
reduce the mortality rates associated with TNBC. Further research examining the
covariates used in the study is needed to reinforce the results found in this study.

	
  
II.

INTRODUCTION

Breast cancer is the most commonly diagnosed cancer in women in the United
States, with more than 230,000 cases in 2013 (U.S. Cancer Statistics Working
Group, 2016). In the United States, breast cancer is also the second leading cause
of cancer death in women (U.S. Cancer Statistics Working Group, 2016). According
the National Cancer Institute, breast cancer is defined as a cancer that forms in the
tissues of the breast, and it is considered invasive if the breast cancer has spread
from where it began to the surrounding tissue. Breast cancer is typically categorized
by the presence or absence of human epidermal growth factor receptor 2 (HER2)
and hormone-receptor expression (Elias, 2010). This paper will focus on triple
negative breast cancer (TNBC) and possible predictors of this subtype of breast
cancer. TNBC lacks HER2 amplification, progesterone receptor (PR) expression,
and estrogen receptor (ER) expression (Reyes, et al., 2017).
TNBC accounts for about 15%-20% of all cases of breast cancer (Reyes, et al.,
2017). It tends to be more aggressive than other subtypes of breast cancer,
generally affects younger women, has been shown to have poorer 5-year survival
rates, and has greater chances of metastases and recurrence than other forms of
breast cancer (Elias, 2010; Reyes, et al., 2017; Kawai, et al, 2014). Because of the
aggressive nature and higher likelihood of affecting younger women, understanding
the sociodemographic and clinical predictors of TNBC is important. However,
relatively few current publications focus on risk factors for TNBC versus other
subtypes of breast cancer (Hudis, et al., 2011).

	
  
There are many known risk factors for breast cancer, but few have been
examined related to specific subtypes of breast cancer, such as TNBC. Menopausal
status, tobacco use, family history, and race are all associated with the risk of breast
cancer (Kawai, et al., 2014; Howell, et al., 2014). This paper further examines these
risk factors in terms of their association with TNBC. This paper will also examine
whether marital status and insurance status are risk factors for TNBC. Married
women have been shown to have lower mortality rates when compared with
unmarried cancer patients (Martinez, et al., 2017). The main goal of this research is
to determine which factors may be related to a higher risk of death in patients with
TNBC. A secondary goal is to determine if higher mortality is related to TNBC over
all other subtypes of breast cancer.
III.

LITERATURE REVIEW

The review of literature given below examines the currently known information
related to TNBC and its potential risk when compared with other forms of breast
cancer. The information contained comes from published journal articles, national
and international organizations reports, and public health organization web sites and
fact sheets. PubMed was the major database used to find and access the journal
articles of interest.
Breast cancer is a major contributor to incidence and mortality rates for cancer in
the United States. This is largely due to the increasing number of women who have
many risk factors for breast cancer. These factors include younger age of first
menarche, later age of first pregnancy, lower number of overall pregnancies, shorter
time or no time spent breastfeeding, and a later age of menopause (Howell, et al.,

	
  
2014; Turkoz, et al., 2013). Other factors that have been shown to contribute to the
risk of breast cancer include age and family history. Studies have shown links for
both of these risk factors related to all breast cancer types collectively (Turkoz, et al.,
2013). However, little work has been done specifically examining the effects of age
and family history on TNBC patients. One study found that a higher proportion of
patients with family history were found within the TNBC patients over the other
breast cancer subtypes, but the results were not significant (Turkoz, et al., 2013).
Because of their lack of receptor expression, TNBC tumors are more difficult to
treat with targeted therapy, and are mainly treated with cytotoxic chemotherapy
(Bae, et al., 2016; Elias, 2010; Reyes, et al., 2017). Some (but few) studies have
examined the risk of TNBC compared to other subtypes of breast cancer and have
found that TNBC patients have poorer survival rates (Kawai, et al., 2014; Turkoz, et
al., 2013). These studies also showed that there is a poorer survival rate for nonHispanic black women than for all other women with TNBC (Elias, 2010; Kawai, et
al., 2014). There have been mixed results relating to smoking and risk of breast
cancer. One review found that current smokers had a 15%-40% increased risk of
premenopausal breast cancer (Johnson, et al., 2011; Kawai, et al., 2014). Some
studies have examined the effect of smoking on breast cancer tumor by subtype but
did not appear to show a link between smoking and the risk of TNBC (Kawai, et al.,
2014).
Studies have also examined the effects of marital status on mortality rates in
breast cancer. One study found that unmarried individuals diagnosed with breast
cancer had higher mortality risk than married breast cancer patients (Martinez, et al.,

	
  
2017). This shows that marital status may have an important relationship with
mortality among female cancer patients, but it does not examine if this risk differs
among the different subtypes of breast cancer.
Due to the aggressive nature of TNBC and the greater likelihood of this subtype
affecting young women, the risk factors associated with TNBC need to be further
examined to determine which factors may be more likely to lead to an increased risk
of death with TNBC. There are few studies that examine the effects of family history,
marital status, menopausal status at diagnosis, and family history on the risk of
death due to TNBC or if there are differences in the factors associated with TNBC
compared to other subtypes of breast cancer.

IV.

SPECIFIC AIMS

To provide additional information related to covariates associated with risk of
death in TNBC patients.
V.

OBJECTIVES

To determine whether an association exists between the risk of death in TNBC
patients and race, age, tobacco use, family history, marital status, insurance status,
menopausal status and stage at diagnosis.
To determine whether there is a difference in survival for TNBC patients when
compared to all patients with other subtypes of breast cancer.

	
  
VI.

METHODS

Study Design
This study is a retrospective cross-sectional study that uses secondary data.
All data related to type of breast cancer, race, tobacco use, age at diagnosis, family
history, marital status, insurance status, menopausal status at diagnosis, stage at
diagnosis and survival status was available at the individual patient level.
Study Population
The study population consists of Kentucky women, age 18 and older that
have been diagnosed with any form of breast cancer so long as the specific
molecular subtype is known. The data consists of cases diagnosed from 2009 to
2014, as this is when the Kentucky Cancer Registry (KCR) began recording the
specified subtype of TNBC. KCR is an ongoing, population-based cancer registry
that is specific to the state of Kentucky. It is designed to collect and analyze cancer
patient information related to diagnosis and treatment. KCR contacts cases at least
once a year to obtain data related to health, vital status, and disease progression.
There were 18,456 cases of breast cancer diagnosed and recorded by KCR
during the five-year period. Cases with unknown or undocumented subtype were
excluded (n=5,035), resulting in 13,421 cases of breast cancer eligible for inclusion.
As there were very few individual cases identified under race categories other than
white or black, race was sorted into only those two categories. Excluding cases
recorded as unknown or of other races (n=121) left 13,300 breast cancer cases.
Those with unknown tobacco use were excluded (n=1,718), as well as those with

	
  
unknown family history (n=1,651), unknown menopausal status (n=1,016), and
unknown marital status were excluded (n=112), and those with unknown insurance
payer status were excluded (n=18). Finally, those with unknown stage of cancer at
diagnosis were excluded (n=55).
After the exclusions stated above, the final study population consisted of
8,730 cases of breast cancer: 1,145 cases of triple negative breast cancer and 7,585
cases of all other types of breast cancer. The University of Kentucky Institutional
Review Board reviewed and approved the study protocol.
Outcome Assessment
Records pertaining to breast cancer cases that were reported to the Kentucky
Cancer Registry were used. The CS site-specific factor 16 was used to determine
the subtype of cancer as being triple negative or all other subtypes. The TNBC
cases were then analyzed with the covariates of interest and the known patient
status (dead or alive).
Demographic Covariates
Besides the assessment of breast cancer subtype, the covariates of interest
in the breast cancer patients are race, age at diagnosis, tobacco use, family history,
marital status, insurance status and menopausal status at diagnosis. Race has been
limited to white and black groupings and tobacco use has been grouped into never
used tobacco and users of any type of tobacco. Marital status has multiple
categories: single, married, separated or divorced, widowed, and unmarried or with
domestic partner. Family history was grouped into known family history or no family

	
  
history. Insurance status has been grouped into a total of four categories: uninsured,
privately insured, receives Medicaid, and receives Medicare. Menopausal status has
been grouped into pre-menopausal and post-menopausal. Stage at diagnosis has
been reduced to two categories: early stage and late stage. Stages 0, 1, and 2 are
grouped under the early category and stages 3 and 4 are grouped under the late
category. All covariates used were chosen based on previous literature and the
possibility of the covariates linked with specific breast cancer types.
Statistical Methods
Univariate analysis was used to report the characteristics of the entire study
population and to determine the characteristics of the study population separated by
cancer subtype. Chi-square and logistic regression models were used to determine
the odds of survival related to TNBC and the covariates of interest. The relationship
between the covariates and survival was analyzed with both bivariate and
multivariate analysis. Statistically significant relationships in the bivariate and logistic
regression were determined with chi-square tests (p ≤ 0.05). Survival status for the
breast cancer cases based on the cancer subtype was determined by survival
curves. Cox proportional-hazard regression was used to determine the risk of death
due to breast cancer using the following covariates: race, age at diagnosis, tobacco
use, family history, marital status, insurance status, and menopausal status at
diagnosis. Death was documented through February 2017 with cases of last contact
of more than one year being censored. Survival interval was used as the time
component and was determined from date of diagnosis to date of death (or last
contact in censoring).

	
  
Statistical significance was determined using a p-value ≤ 0.05. All analyses
were carried out using SAS 9.4® (SAS Institute, Inc.; Cary, NC). Data used in this
publication were provided by the Kentucky Cancer Registry, Lexington, Kentucky.

VII.

RESULTS

The majority of the patients included in the study were white (92.68%) nontobacco users (56.80%), without a family history of breast cancer (57.22%), and
married (58.67%) (Table 1). Most of the patients were privately insured or covered
with Medicaid or Medicare, with very few being uninsured (2.16%). A large majority
of all patients also were documented as being post-menopausal at diagnosis
(76.60%), diagnosed at an early stage (83.89%) and were currently determined to
be living (86.43%). Of all the documented cases of breast cancer included in the
study, 13.12% of these cases were categorized as triple negative.
The characteristics of the patient population specific to TNBC and all other
subtypes are given in Table 2. The TNBC population, compared to the population of
patients with other breast cancer subtypes, was more likely to include black women
(11.53% vs. 6.68%), women with private insurance (53.62% vs. 48.69%), women on
Medicaid (10.74% vs. 7.49%), and more diagnosed at a late stage (19.74% vs.
15.56%). On average, the age of the TNBC patients included in the study population
was 58.2 ± 12.8 years old, while the age of the patients with other breast cancer
subtypes was 61.5 ± 12.7 years old.
Bivariate analysis was used to determine significant association of covariates
and death for patients with TNBC (Table 3). The results showed that race and family

	
  
history were not associated with death among women with TNBC. Whereas, tobacco
use, age at diagnosis, marital status, primary payer status, menopausal status and
stage at diagnosis were significantly associated with death. For example, 75.79% of
tobacco users were survivors compared to 81.16% of non-tobacco users.
The point estimates for the odds ratios with 95% confidence intervals
obtained through logistic regression are given in Table 4. The odds ratios are based
on data for TNBC patients, excluding all other cancer subtypes in the study
population. Of the ratios showing statistical significance, women who were widowed
had 1.70 (95% CI: 1.06, 2.72) times the odds of dying with TNBC when compared to
married women. Women who were on Medicare had 2.59 (95% CI: 1.49, 4.51) times
the odds of dying with TNBC when compared to privately insured women. Women
who were uninsured had 3.04 (95% CI: 1.26, 7.35) times the odds of dying with
TNBC when compared to privately insured women. Women who were diagnosed at
a late stage had 9.46 (95% CI: 6.62, 13.53) times the odds of dying with TNBC when
compared to women who were diagnosed at an earlier stage. The c value for the
model was 0.803, meaning that the model has adequate discriminatory accuracy
(Chen, et al., 2003; Howell, et al., 2014).
Logistic regression was also used to determine the odds ratios with 95%
confidence intervals for the odds of dying based on breast cancer subtype. The
results were statistically significant and show that patients diagnosed with TNBC
have 2.24 (95% CI: 1.90, 2.64) times the odds of dying than patients diagnosed with
other breast cancer subtypes.

	
  
The survival curve given in Figure 1 shows the differences in survival rates
between patients with TNBC and patients with all other subtypes of breast cancer.
Both the log-rank test (p<0.0001) and the Wilcoxon test (p<0.0001) show a
statistically significant difference between the two curves, meaning that those with
TNBC have a lower probability of survival than those with other breast cancer
subtypes. The survival curve given in Figure 2 shows the differences in survival
rates for TNBC patients who were married, single, separated or divorced, or
widowed. Both the log-rank test (p<0.0001) and the Wilcoxon test (p=0.0002) show
a statistically significant difference between the curves. The survival curve in Figure
3 shows the differences in survival rates for TNBC patients who were privately
insured, on Medicaid, on Medicare, or who were uninsured. Both the log-rank test
(p<0.0001) and the Wilcoxon test (p<0.0001) show a statistically significant
difference between the curves. The survival curve in Figure 4 shows the differences
in survival rates for TNBC patients who were diagnosed at an early stage or at a late
stage. Both the log-rank test (p<0.0001) and the Wilcoxon test (p<0.0001) show a
statistically significant difference between the curves.
Two Cox regressions were estimated, one with all breast cancer subtypes to
test the hazard of death for TNBC versus all other subtypes, and a second to test
the impact of the covariates on TNBC patients only (Table 5). The statistically
significant results showed that patients with TNBC had 1.78 (95% CI: 1.55, 2.06)
times the hazard of dying when compared to patients with all other breast cancer
subtypes. The results of the cox regression for TNBC only patients are given in
Table 6. Of the hazard ratios showing statistical significance for those diagnosed

	
  
with TNBC, single women have 1.63 (95% CI: 1.06, 2.50) times the hazard of dying
when compared to married women. Women on Medicaid have 1.81 (95% CI: 1.13,
2.88) times the hazard of dying when compared to privately insured women. Women
on Medicare have 2.73 (95% CI: 1.77, 4.20) times the hazard of dying when
compared to privately insured women, and uninsured women have 2.98 (95% CI:
1.57, 5.68) times the hazard of dying when compared to privately insured women.
Women diagnosed as late stage have 6.54 (95% CI: 5.03, 8.49) times the hazard of
dying when compared to women diagnosed as early stage.

VIII.

DISCUSSION

Primary Findings
This study was used to examine the potential risks associated with TNBC and
death from TNBC. It assessed the association of TNBC with race, tobacco use,
family history, marital status, primary payer status, menopausal status at diagnosis,
and stage at diagnosis. All cancer cases in Kentucky over a five-year period were
analyzed with cases being grouped by breast cancer subtype.
The results suggest that the TNBC cases had an overall lower age than all other
subtypes (58.2 vs. 61.5). Characteristics that may be associated with lower age also
are seen to differ in TNBC cases: with a slightly larger percentage of TNBC patients
being single (10.57% vs. 9.29%) and being on Medicaid (10.74% vs. 7.49%). There
were also fewer TNBC patients widowed (13.71% vs. 17.75%) and on Medicare
(32.58% vs. 41.79%). These noted differences in age, as well as the hazard of death

	
  
associated with late stage diagnosis (HR: 6.54; 95% CI: 5.03, 8.49), support the
current standards of beginning mammography screening at the slightly younger age
of 40 (Breast Cancer, 2016).
The results showed many covariates being significantly associated with death in
the bivariate analyses (Table 3) but age at diagnosis, tobacco use, and menopausal
status were no longer significant in the multivariate analysis. Further studies can be
compared to these results to see if the results are corroborated in populations other
than Kentucky.
The results also show that married woman had a lower risk of TNBC and lower
hazard of dying than women that were single, widowed, or separated or divorced.
This may be due to health factors related to happiness and companionship or due to
the fact that a partner may help notice signs and obtain treatment early on if this is a
factor. Insurance status also appears to be significantly related to TNBC diagnosis
with privately insured women having a lower risk of TNBC than women who are
uninsured, on Medicaid, or on Medicare. This may be related to the SES of the
women as those who are privately insured generally have a higher economic
standing than those who are uninsured, on Medicaid, or on Medicare.
Comparison with Other Studies
The percentage of the study population diagnosed with TNBC support the
numbers found in other studies, this study found those with TNBC to account for
13.12% of the population and other sources generally found it to be between 10%20% (U.S. Cancer Statistics Working Group, 2016; Reyes, et al., 2017). Previous
studies, and this current study did not find significant links between family history

	
  
and risk of TNBC or between smoking and risk of TNBC (Turkoz, et al., 2013).
However, this current study examined additional covariates not found in Turkoz, et
al. (2013) to add to its understanding of associated risk factors.
Other studies contribute to the understanding of smoking and risk of breast
cancer, our study found smoking to be significantly associated with the risk of death,
in the bivariate analysis only. This supports the findings in the Kawai, et al. study, in
their multivariate analyses; they did not find a significantly increased risk of TNBC in
patients with a smoking history (Kawai, et al., 2014). Further examination would be
needed to support this with the inclusion of other confounders.
Payer status has been shown in previous studies to be significantly related to
survival status, this is likely due to payer status being a known barrier to access to
treatment (Shi, et al., 2015). The study found that higher mortality was associated
with breast cancer patients on Medicaid or with no insurance (Shi, et al., 2015). Our
study went further by separating the breast cancer cases by subtype and found that
Medicaid, Medicare, and uninsured TNBC patients had a significantly higher risk of
death than privately insured patients. This furthers the Shi, et al. study in that
primary payer status is related to aggressive breast cancer and mortality rates.
Studies have examined marital status and its association with breast cancer.
One study found that unmarried breast cancer patients had significantly higher risk
for death than married patients (Martinez, et al., 2017). Although not all of our
findings were significant, they did show an increased risk of death for patients that
were single, widowed, and separated or divorced when compared to married
patients. Our findings were significant in showing an increased hazard of dying for

	
  
patients who were single or widowed when compared with married patients. These
results add support to the Martinez, et al. study and show the need for further
studies to determine if there is significant association between the risk of death from
TNBC and marital status.
The survival curves presented in Figure 1 add further support to the
knowledge that TNBC is a more aggressive subtype of breast cancer (Bae, et al.,
2016; Elias, 2010; U.S. Cancer Statistics Working Group, 2016). The TNBC curve
showed a significantly lower probability of survival than the curve for all other breast
cancer subtypes.
Strengths and Limitations
A strength of this study is the relatively large sample size used for analysis as
other studies found in the literature had much lower sample sizes. A large sample
size gives strength to the results of the analysis. This study also provided
information related to covariates specific to TNBC that has not been shown in other
studies. This is a strength because the study was able to contribute new
understanding to the issues of breast cancer and the TNBC subtype.
This study also had several limitations. The study only examined
retrospective data and did not have information related potential changes in
screening methods over time. If women began screening earlier or later during the
time period, this could have affected the recorded age at diagnosis. The study also
did not examine the cancer cases by treatment used or comorbidities. These factors
may have an effect on mortality and could provide useful information in a future
study. Another limitation may be from the use of marital status at diagnosis in the

	
  
study. The results on survival are based on this variable but they do not show if an
individual’s marital status changed from diagnosis to death, which may have had an
effect on the health of the patient. Further, more factors may have been examined
as possible risk factors for TNBC in this study to improve the understanding of what
is a risk factor for diagnosis of TNBC or a risk factor for increased death due to
TNBC. Other factors of interest in studies that may have been used include obesity
and diabetes.
Conclusions
This study contributes to the understanding of risk factors related to TNBC
and the need for continued early screening and treatment to help reduce the
mortality rates of TNBC. The covariates and outcomes in this study are only a few of
those of interest and further examination of risk related to diagnosis of TNBC and
death due to TNBC is needed. Overall, screening is key as TNBC is aggressive and
leads to higher mortality; early diagnosis and treatment may be beneficial to a
reduction in these rates.
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Table 1: Characteristics of patients diagnosed with breast cancer between
2009-2014 in the study population.
Variables

N

%

8730

61.089 (12.805)

8091
639

92.68%
7.32%

4939
3756

56.80%
43.20%

3735
4995

42.78%
57.22%

826
5122
1263
1503
16

9.46%
58.67%
14.47%
17.22%
0.18%

189
4307
691
3543

2.16%
49.34%
7.92%
40.58%

2043
6687

23.40%
76.60%

7545
1185

86.43%
13.57%

1145
7585

13.12%
86.88%

7324
1406

83.89%
16.11%

Age
Mean (Standard Deviation)
Race
White
Black
Tobacco Use
Never Used
Used Any Tobacco
Family History
Yes
No
Marital Status
Single
Married
Separated or Divorced
Widowed
Unmarried or Domestic Partner
Primary Payer
Uninsured
Privately Insured
Medicaid
Medicare
Menopausal Status at Diagnosis
Pre-Menopausal
Post-Menopausal
Vital Status
Alive
Dead
Breast Cancer Subtype
Triple Negative
All Other Subtypes
Stage at Diagnosis
Early
Late

	
  
	
  

	
  
Table 2: Characteristics of the patient population separated by subtype.
TNBC
Variables
Age
Mean (Standard Deviation)
Race
White
Black

Other Subtypes
N
%

N

%

1145

58.211 (12.848)

7585

61.523 (12.743)

1013
132

88.47%
11.53%

7078
507

93.32%
6.68%

Tobacco Use
Never Used
Used Any Tobacco

637
504

55.83%
44.17%

4302
3252

56.95%
43.05%

Family History
Yes
No

510
635

44.54%
55.46%

3225
4360

42.52%
57.48%

Marital Status
Single
Married
Separated or Divorced
Widowed
Unmarried or Domestic Partner

121
698
169
157
0

10.57%
60.96%
14.76%
13.71%
0%

705
4424
1094
1346
16

9.29%
58.33%
14.42%
17.75%
0.21%

Primary Payer
Uninsured
Privately Insured
Medicaid
Medicare

35
614
123
373

3.06%
53.62%
10.74%
32.58%

154
3693
568
3170

2.03%
48.69%
7.49%
41.79%

Menopausal Status at Diagnosis
Pre-Menopausal
Post-Menopausal

308
837

21.14%
78.86%

1735
5850

22.87%
77.13%

Vital Status
Alive
Dead

903
242

78.86%
21.14%

6642
943

87.57%
12.43%

919
226

80.26%
19.74%

6405
1180

84.44%
15.56%

Stage at Diagnosis
Early
Late

	
  
Table 3: Bivariate analysis of covariates for TNBC.
TNBC

Chi-Square

Dead (%)

Alive (%)

Black

19.70%

80.30%

White

21.32%

78.68%

Never Used

18.84%

81.16%

Used Tobacco

24.21%

75.79%

No

22.36%

77.64%

Yes

19.61%

80.39%

23-39

16.46%

83.54%

40-64

15.52%

84.48%

65+

33.62%

66.38%

Married

16.62%

83.38%

Separated or Divorced

23.67%

76.33%

Single

25.62%

74.38%

Widowed

35.03%

64.97%

Privately Insured

11.73%

88.27%

Medicaid

21.95%

78.05%

Medicare

35.39%

64.61%

Uninsured

31.43%

68.57%

Pre-Menopausal

13.31%

86.69%

Post-Menopausal

24.01%

75.99%

Early

12.73%

87.27%

Late

55.31%

44.69%

(p-value)

Race
0.6669

Tobacco Use
0.0276

Family History
0.2565

Age at Diagnosis

<0.0001

Marital Status

<0.0001

Primary Payer Status

<0.0001

Menopausal Status
<0.0001

Stage at Diagnosis
<0.0001

	
  
Table 4: Odds ratio estimates for TNBC patients (calculated with logistic
regression)
Effect

Point Estimate

95% Confidence Limits

Race:
Black vs. White

0.788

0.452

1.375

0.764

0.545

1.070

1.084

0.774

1.518

40-64 vs. 23-39

0.697

0.316

1.536

65+ vs. 23-39

1.022

0.382

2.731

Single vs. Married

1.424

0.804

2.524

Separated or Divorced vs. Married

1.505

0.935

2.423

Widowed vs. Married

1.698

1.062

2.715

Uninsured vs. Privately Insured

3.037

1.255

7.349

Medicaid vs. Privately Insured

1.447

0.810

2.586

Medicare vs. Privately Insured

2.593

1.491

4.509

1.438

0.866

2.387

9.462

6.616

13.531

Tobacco Use:
Never Used vs. Cigarettes Smoker
Family History:
Yes vs. No
Age at Diagnosis:

Marital Status:

Primary Payer:

Menopausal Status at Diagnosis:
Post-Menopausal vs. Pre-Menopausal
Stage at Diagnosis:
Late vs. Early

	
  
Figure 1: Survival curve comparing the survival over time (in years) of TNBC
and all other breast cancer subtypes

	
  

	
  
Figure 2: Survival curve comparing the survival over time (in years) for all
TNBC patients based on marital status

	
  
Figure 3: Survival curve comparing the survival over time (in years) for all
TNBC patients based on insurance status.

	
  
Figure 4: Survival curve comparing the survival over time (in years) for all
TNBC patients based on stage at diagnosis.

	
  
Table 5: Hazard ratios for TNBC patient data.
Pr >

Hazard

95% Confidence

ChiSq

Ratio

Limits

0.4983

0.797

0.414

1.536

0.8227

0.913

0.412

2.025

Race: Black

0.3806

0.825

0.536

1.269

Tobacco Use: Never Used Tobacco

0.0817

0.794

0.612

1.030

Family History: Yes

0.9023

0.984

0.757

1.278

Marital Status at Diagnosis: Single

0.0253

1.628

1.062

2.497

Widowed

0.1280

1.310

0.925

1.855

Separated or Divorced

0.1078

1.356

0.936

1.966

Primary Payer: Medicaid

0.0128

1.805

1.134

2.875

Medicare

<0.0001

2.725

1.767

4.203

Uninsured

0.0009

2.983

1.568

5.677

Menopausal Status at Diagnosis: Post-menopausal

0.1117

1.411

0.923

2.156

Stage at Diagnosis: Late Stage

<0.0001

6.535

5.033

8.486

Age at Diagnosis: 40-64
65+

